These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 26687615)
1. Health state utility instruments compared: inquiring into nonlinearity across EQ-5D-5L, SF-6D, HUI-3 and 15D. Gamst-Klaussen T; Chen G; Lamu AN; Olsen JA Qual Life Res; 2016 Jul; 25(7):1667-78. PubMed ID: 26687615 [TBL] [Abstract][Full Text] [Related]
2. Comparing and explaining differences in the magnitude, content, and sensitivity of utilities predicted by the EQ-5D, SF-6D, HUI 3, 15D, QWB, and AQoL-8D multiattribute utility instruments. Richardson J; Khan MA; Iezzi A; Maxwell A Med Decis Making; 2015 Apr; 35(3):276-91. PubMed ID: 25159172 [TBL] [Abstract][Full Text] [Related]
3. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service. Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412 [TBL] [Abstract][Full Text] [Related]
4. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis. Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061 [TBL] [Abstract][Full Text] [Related]
5. Accounts from developers of generic health state utility instruments explain why they produce different QALYs: A qualitative study. Pickles K; Lancsar E; Seymour J; Parkin D; Donaldson C; Carter SM Soc Sci Med; 2019 Nov; 240():112560. PubMed ID: 31563007 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD). Yang F; Lau T; Lee E; Vathsala A; Chia KS; Luo N Eur J Health Econ; 2015 Dec; 16(9):1019-26. PubMed ID: 25519850 [TBL] [Abstract][Full Text] [Related]
7. Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis. Lillegraven S; Kristiansen IS; Kvien TK Ann Rheum Dis; 2010 Oct; 69(10):1762-7. PubMed ID: 20448285 [TBL] [Abstract][Full Text] [Related]
8. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments. Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372 [TBL] [Abstract][Full Text] [Related]
9. Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal. Lamu AN; Björkman L; Hamre HJ; Alræk T; Musial F; Robberstad B Health Qual Life Outcomes; 2021 Apr; 19(1):125. PubMed ID: 33865400 [TBL] [Abstract][Full Text] [Related]
10. A conceptual map of health-related quality of life dimensions: key lessons for a new instrument. Olsen JA; Misajon R Qual Life Res; 2020 Mar; 29(3):733-743. PubMed ID: 31676970 [TBL] [Abstract][Full Text] [Related]
11. Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis. Thaweethamcharoen T; Noparatayaporn P; Sritippayawan S; Aiyasanon N Value Health Reg Issues; 2019 May; 18():59-64. PubMed ID: 30502661 [TBL] [Abstract][Full Text] [Related]
13. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia. McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564 [TBL] [Abstract][Full Text] [Related]
14. Quality-adjusted life expectancies in patients with rheumatoid arthritis--comparison of index scores from EQ-5D, 15D, and SF-6D. Sørensen J; Linde L; Ostergaard M; Hetland ML Value Health; 2012; 15(2):334-9. PubMed ID: 22433765 [TBL] [Abstract][Full Text] [Related]
15. Quality of Life and General Health After Elective Surgery for Cervical Spine Pathologies: Determining a Valid and Responsive Metric of Health State Utility. Chotai S; Parker SL; Sivaganesan A; Godil SS; McGirt MJ; Devin CJ Neurosurgery; 2015 Oct; 77(4):553-60; discussion 560. PubMed ID: 26191977 [TBL] [Abstract][Full Text] [Related]
16. Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D. Lamu AN; Olsen JA Qual Life Res; 2018 Nov; 27(11):2823-2839. PubMed ID: 30173314 [TBL] [Abstract][Full Text] [Related]
17. Which approach is better in eliciting health state utilities from breast cancer patients? Evidence from mainland China. Li S; Wang M; Liu L; Chen G Eur J Cancer Care (Engl); 2019 Mar; 28(2):e12965. PubMed ID: 30499193 [TBL] [Abstract][Full Text] [Related]
18. A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD). Chen J; Wong CK; McGhee SM; Pang PK; Yu WC PLoS One; 2014; 9(11):e112389. PubMed ID: 25379673 [TBL] [Abstract][Full Text] [Related]
19. The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure. Kontodimopoulos N; Argiriou M; Theakos N; Niakas D Eur J Health Econ; 2011 Aug; 12(4):383-91. PubMed ID: 20473544 [TBL] [Abstract][Full Text] [Related]
20. The responsiveness of quality of life utilities to change in depression: a comparison of instruments (SF-6D, EQ-5D, and DFD). Gerhards SA; Huibers MJ; Theunissen KA; de Graaf LE; Widdershoven GA; Evers SM Value Health; 2011; 14(5):732-9. PubMed ID: 21839412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]